Ruurd Stolp
President at Intervet, Inc.
Profile
Dr. Ruurd Stolp is President at Intervet, Inc. He is on the Board of Directors at Malcisbo AG.
Dr. Stolp was previously employed as President by Intervet International BV and President by Intervet.
He received his undergraduate degree from the University of Utrecht.
Ruurd Stolp active positions
Companies | Position | Start |
---|---|---|
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Intervet, Inc. develops, manufactures, and sales animal health products. It provides healthcare products for pets, livestock, poultry, and aquaculture. The company was founded in 1982 and is located in Millsboro, DE. | President | - |
Former positions of Ruurd Stolp
Companies | Position | End |
---|---|---|
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Merck Animal Health develops, manufactures and markets a range of veterinary medicines and services. It offers products for the prevention, treatment and control of diseases in farm and companion animal species. The firm provides veterinary pharmaceuticals, vaccines and health management solutions, farmers, pet owners and governments worldwide. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | President | 2007-12-31 |
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | President | 2007-01-01 |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Director/Board Member | - |
Training of Ruurd Stolp
University of Utrecht | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Health Technology |
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Intervet, Inc. develops, manufactures, and sales animal health products. It provides healthcare products for pets, livestock, poultry, and aquaculture. The company was founded in 1982 and is located in Millsboro, DE. | Process Industries |
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Merck Animal Health develops, manufactures and markets a range of veterinary medicines and services. It offers products for the prevention, treatment and control of diseases in farm and companion animal species. The firm provides veterinary pharmaceuticals, vaccines and health management solutions, farmers, pet owners and governments worldwide. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Health Technology |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Ruurd Stolp